RÉSUMÉ
Resumen Introducción: La manía unipolar (MU) es un trastorno que se comporta de manera distinta al trastorno bipolar-I (TB-I), sin embargo, no es considerado como una entidad independiente por los manuales diagnósticos vigentes, sino que es incluido dentro del diagnóstico de TB-I. Caso clínico: Hombre de 21 años presenta cuadro clínico de 3 meses de evolución caracterizado por ánimo exaltado y síntomas psicóticos congruentes al estado de ánimo. El paciente niega episodios depresivos previos. Se instaura tratamiento con litio y aripiprazol que resulta satisfactorio, sin presentar recurrencias tras 5 años de seguimiento. Revisión de la literatura y discusión: Los manuales diagnósticos describen que para diagnosticar TB-I no se requiere la presencia de un episodio depresivo mayor, lo que implica que pacientes con MU quedan dentro de la misma categoría diagnóstica que pacientes con TB-I. Diferencias entre MU y TB-I han sido demostradas en estudios epidemiológicos, clínicos y genéticos, por lo tanto, incluir pacientes heterogéneos dentro de la misma categoría podría dificultar la interpretación de estudios y limitar los avances en el conocimiento de ambos trastornos. Conclusión: De la revisión de la literatura se sugiere que la MU debe ser reconocida como un diagnóstico independiente. A pesar de su baja prevalencia, al validarlo como tal, en un futuro podríamos contar con mayor cantidad y mejor calidad de datos sobre este. De esta forma se podrá definir de manera más concreta sus características distintivas, y por consiguiente mejorar el abordaje clínico de estos pacientes.
Introduction: Unipolar mania (UM) is a disorder that behaves differently from bipolar-I disorder (BP-I), however, it is not considered an independent entity by current diagnostic manuals, but rather included within the diagnosis of BP-I. Case report: A 21-year-old man presented a 3-month-long episode characterized by exalted mood and mood-congruent psychotic symptoms. The patient denies previous depressive episodes. Treatment with lithium and aripiprazole was established, which was satisfactory, not showing recurrence after 5 years of follow-up. Literature review and discussion: Diagnostic manuals describe that to diagnose BP-I the presence of a major depressive episode is not required, which implies that patients with UM fall into the same diagnostic category as patients with BP-I. Differences between UM and BP-I have been demonstrated in epidemiological, clinical, and genetic studies, therefore, including heterogeneous patients within the same category could hinder the interpretation of studies and limit advances in the knowledge of both disorders. Conclusion: Based on the literature review, it is suggested that UM should be recognized as an independent diagnosis. Despite its low prevalence, by validating it as such, in the future we could have more and better-quality data about this diagnosis. In this way, its distinctive characteristics can be defined more concretely, and therefore improve the clinical approach of these patients.
Sujet(s)
Humains , Mâle , Adulte , Trouble bipolaire/diagnostic , Trouble bipolaire/classification , Trouble bipolaire/traitement médicamenteux , Aripiprazole/usage thérapeutique , Lithium/usage thérapeutiqueRÉSUMÉ
Introducción: El secuestro pulmonar (SP) ha sido tratado por muchos años con cirugía convencional efectuando remoción del tejido pulmonar ectópico y ligadura de los vasos sanguíneos aberrantes que nacen desde la aorta. Existe evidencia establecida, especialmente en literatura de habla inglesa que apoya el uso de la embolización arterial transcatéter mediante dispositivo para ocluir el vaso anómalo, como una opción de tratamiento seguro y definitivo para el SP intralobar. Objetivo: Mostrar nuestra experiencia pionera de la técnica de tratamiento del SP por medio de embolización transcatéter. Caso clínico: Presentamos los casos clínicos de dos adolescentes, de 13 y 14 años y de un recién nacido de 26 días de vida, portadores de SP intralobar, cuyos diagnósticos se realizaron a través de Tomografía Axial Computarizada (TAC) con contraste, tratados mediante embolización arterial transcatéter, con buen resultado y sin complicaciones en el seguimiento precoz y tardío. Conclusión: Con este tratamiento se logra en los pacientes afectados de SP resultados definitivos, menos invasivos y sin complicaciones al seguimento.
Introduction: Pulmonary sequestration (PS) has been treated for many years with conventional surgical removal of the ectopic lung tissue and ligation of aberrant vessels that arise from the aorta. There is evidence, especially in English-language literature that supports the use of transcatheter arterial embolization through a device for occlusion of the anomalous vessel, as a safe option and definitive treatment for intralobar PS. Objective: To show our experience pioneering the technique of PS treatment through transcatheter embolization. Case report: The case reports of two teenagers aged 13 and 14 and a 26-day-old newborn that developed intralobar PS are described. The diagnosis was made through computerized axial tomography (CT scan) and successfully and without complication, during early and long term follow-up, treated by arterial embolization transcatheter. Conclusion: The use of transcatheter arterial embolization is a less invasive and definitive treatment for patients with PS.
Sujet(s)
Humains , Mâle , Adolescent , Femelle , Nouveau-né , Embolisation thérapeutique/méthodes , Séquestration bronchopulmonaire/thérapie , Embolisation thérapeutique/instrumentation , Séquestration bronchopulmonaire , Tomodensitométrie , Résultat thérapeutique , Vaisseaux sanguins/malformationsSujet(s)
Adénosine/administration et posologie , Antagonistes bêta-adrénergiques/administration et posologie , Inhibiteurs des canaux calciques/administration et posologie , Sinus carotidien , Ablation par cathéter , Défibrillation , Électrocardiographie , Humains , Massage , Tachycardie supraventriculaire/classification , Manoeuvre de VasalvaSujet(s)
Électrocardiographie , Femelle , Humains , Mâle , Tachycardie supraventriculaire/classificationRÉSUMÉ
The availability of counterfeit and poor quality drugs contribute to resistance and erroneous efficacy study results as well as directly affecting the health of individuals. This report describes the importance of drug quality monitoring as part of a comprehensive disease surveillance program.
Sujet(s)
Antipaludiques/usage thérapeutique , Surveillance des médicaments , Résistance aux substances , Humains , Paludisme/traitement médicamenteux , Contrôle de qualitéRÉSUMÉ
Introduction The shortage of general practitioners is a worldwide phenomenon and occurs in countries such as Canada; the United States of America and Saudi Arabia. Increasingly fewer students are interested in general practice as an occupation. Choosing a speciality is a complex process and is dependent on a wide range of intrinsic and extrinsic factors; including preference at the start of studies; experience during undergraduate training; and environmental factors such as cultural and socio-economic background. The aim of this study was to determine the profile of registrars at theFaculty of Health Sciences (University of the Free State); as well as their reasons for specialisation. Method All departments were contacted and the first author circulated questionnaires and informed consent forms during the academic afternoons. Questionnaires and informed consent forms were available in Afrikaans and eng. Results Of the 150 questionnaires handed out; 109 were used for analysis (122 were received; of which 13 were incomplete). Most of the respondents were Afrikaans speaking (81.7
Sujet(s)
Éducation pour la santé , Soins de santé primaires , Perfectionnement du personnelRÉSUMÉ
Multicentric angiofollicular lymph node hyperplasia (MAFH) is a variant of Castleman's disease, localized angiofollicular lymph node hyperplasia. Unlike Castleman's disease, MAFH sometimes runs an aggressive clinical course culminating in death, mainly from infection and rarely from malignant lymphoma. the lymphoma may develop months or years after the onset of MAFH but may be present at the time of diagnosis. In this paper, we present a case of MAFH with co-existing peripheral T-cell lymphoma, in a 59-year-old man who died from disseminated disease. This adds another to the list of five such cases recorded in the literature since the recognition of MAFH